Pontiano Kaleebu Selected Research

Pontiano Kaleebu Research Topics

Disease

25	Infections 06/2022 - 07/2005
16	HIV Infections (HIV Infection) 06/2022 - 09/2006
10	Disease Progression 06/2022 - 05/2004
5	COVID-19 01/2022 - 01/2021
5	Tuberculosis (Tuberculoses) 01/2021 - 07/2014
5	Acquired Immunodeficiency Syndrome (AIDS) 01/2016 - 05/2002
4	Schistosomiasis (Bilharziasis) 01/2021 - 01/2018
4	Sexually Transmitted Diseases (Sexually Transmitted Disease) 07/2015 - 01/2011
3	Malaria 01/2021 - 07/2014
3	Superinfection 01/2018 - 09/2014
2	Type 2 Diabetes Mellitus (MODY) 04/2022 - 11/2013
2	Syphilis 01/2022 - 10/2011
2	Parasitic Diseases (Parasitic Disease) 01/2021 - 01/2019
2	Yellow Fever 01/2021 - 07/2014
2	Hypertension (High Blood Pressure) 11/2020 - 01/2017
2	Cryptococcal Meningitis 11/2020 - 01/2019
2	Hepatitis C 01/2019 - 04/2008
2	Schistosomiasis mansoni 01/2018 - 05/2017
2	Neoplasms (Cancer) 01/2014 - 12/2010
2	Coronary Artery Disease (Coronary Atherosclerosis) 11/2013 - 11/2013
1	Chronic Disease (Chronic Diseases) 04/2022
1	Sleep Initiation and Maintenance Disorders (Insomnia) 07/2021
1	Tetanus 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Typhoid Fever (Typhoid) 01/2021
1	Persistent Infection 01/2021
1	Mental Disorders (Mental Disorder) 01/2021
1	Diphtheria 01/2021
1	Overweight 11/2020
1	Peripheral Nervous System Diseases (PNS Diseases) 11/2020
1	Obesity 11/2020
1	Coma (Comas) 11/2020
1	Inflammation (Inflammations) 01/2020
1	Diabetes Complications 08/2019
1	Congenital Abnormalities (Deformity) 01/2019
1	Ebola Hemorrhagic Fever 01/2019
1	Headache (Headaches) 01/2019
1	Pain (Aches) 01/2019
1	Hypersensitivity (Allergy) 01/2018
1	Vaccinia 01/2018
1	Viremia 01/2018
1	Hyperglycemia 01/2017
1	Abdominal Obesity 01/2017
1	Hepatitis B 01/2017
1	Stroke (Strokes) 10/2015
1	HIV Seropositivity 09/2015

Drug/Important Bio-Agent (IBA)

13	VaccinesIBA 01/2022 - 12/2010
5	AntigensIBA 01/2022 - 07/2005
4	CytokinesIBA 06/2022 - 01/2011
4	AIDS VaccinesIBA 10/2020 - 04/2007
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2007
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 01/2017
3	Immunoglobulin G (IgG)IBA 05/2017 - 12/2007
3	AntibodiesIBA 05/2017 - 04/2008
3	Pharmaceutical PreparationsIBA 12/2012 - 01/2011
2	LipidsIBA 04/2022 - 11/2013
2	Broadly Neutralizing AntibodiesIBA 11/2021 - 01/2018
2	MVA 85AIBA 01/2018 - 05/2017
2	Praziquantel (Biltricide)FDA Link 01/2018 - 07/2012
2	Neutralizing AntibodiesIBA 01/2018 - 01/2018
2	RNA (Ribonucleic Acid)IBA 01/2018 - 01/2012
2	Interferon-gamma (Interferon, gamma)IBA 03/2016 - 12/2010
2	Indicators and Reagents (Reagents)IBA 01/2016 - 04/2012
2	Biological ProductsIBA 10/2015 - 01/2015
2	Triglycerides (Triacylglycerol)IBA 11/2013 - 11/2013
2	Peptides (Polypeptides)IBA 04/2012 - 05/2004
1	Interleukin-5 (Interleukin 5)IBA 06/2022
1	Interleukin-7 (Interleukin 7)IBA 06/2022
1	Interleukin-16 (Interleukin 16)IBA 06/2022
1	Interleukin-17 (Interleukin 17)IBA 06/2022
1	Vascular Endothelial Growth Factor DIBA 06/2022
1	Contraceptive Agents (Contraceptives)IBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	COVID-19 VaccinesIBA 01/2021
1	ChemokinesIBA 01/2021
1	Tuberculin (PPD)IBA 01/2021
1	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2021
1	telomerase RNA (bTR)IBA 01/2021
1	Dihydrotachysterol (AT 10)IBA 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 11/2020
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2020
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2020
1	smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordicIBA 01/2019
1	dolutegravirIBA 01/2019
1	Ebola VaccinesIBA 01/2019
1	Reverse Transcriptase InhibitorsIBA 01/2019
1	Antiviral Agents (Antivirals)IBA 01/2019
1	NucleosidesIBA 01/2019
1	HLA-DR Antigens (HLA-DR)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2017
1	oxidized low density lipoproteinIBA 01/2017
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 03/2016
1	Immunoglobulin M (IgM)IBA 10/2015
1	EnzymesIBA 09/2015

Therapy/Procedure

18	Therapeutics 11/2021 - 01/2009
7	Art Therapy 01/2019 - 01/2013
2	Aftercare (After-Treatment) 01/2019 - 07/2012
1	Immunomodulation 01/2021
1	Ambulatory Care (Outpatient Care) 08/2019